報價延遲最少15分鐘:2025/01/21 08:39 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.05 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.46/-0.28
|
|
企業價值
32.27M
|
| 資產負債 |
|
每股賬面淨值
0.03
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
3.45M
|
|
每股收益
0.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:39 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions. |